Free Trial

Extendicare (TSE:EXE) Hits New 12-Month High - Here's Why

Extendicare logo with Medical background

Key Points

  • Extendicare Inc.'s stock reached a new 52-week high of C$15.35, with a last trading price of C$15.30.
  • Several research firms have recently upgraded their price targets for Extendicare, with National Bankshares setting a target of C$17.50 and CIBC at C$18.00, both rating the stock as "outperform."
  • The company announced a monthly dividend of $0.042, translating to an annual yield of 3.3%, with the ex-dividend date set for October 31st.
  • MarketBeat previews top five stocks to own in November.

Extendicare Inc. (TSE:EXE - Get Free Report)'s stock price hit a new 52-week high on Monday . The company traded as high as C$15.35 and last traded at C$15.30, with a volume of 108403 shares traded. The stock had previously closed at C$14.97.

Analyst Ratings Changes

A number of research firms recently issued reports on EXE. National Bankshares upped their price target on shares of Extendicare from C$16.10 to C$17.50 and gave the company an "outperform" rating in a research note on Wednesday, October 8th. CIBC set a C$18.00 price target on shares of Extendicare and gave the company an "outperform" rating in a research note on Monday, September 22nd. Cibc World Mkts raised shares of Extendicare to a "strong-buy" rating in a research note on Monday, September 22nd. Finally, National Bank Financial raised shares of Extendicare to a "strong-buy" rating in a research note on Wednesday, July 16th. Two investment analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of C$15.20.

View Our Latest Stock Report on EXE

Extendicare Stock Up 2.9%

The company's fifty day moving average price is C$13.83 and its 200-day moving average price is C$13.69. The stock has a market cap of C$1.29 billion, a P/E ratio of 15.97 and a beta of 0.88. The company has a debt-to-equity ratio of 283.02, a quick ratio of 0.98 and a current ratio of 0.62.

Extendicare Announces Dividend

The business also recently declared a monthly dividend, which will be paid on Monday, November 17th. Investors of record on Monday, November 17th will be paid a $0.042 dividend. This represents a c) annualized dividend and a yield of 3.3%. The ex-dividend date of this dividend is Friday, October 31st. Extendicare's dividend payout ratio (DPR) is currently 50.57%.

Extendicare Company Profile

(Get Free Report)

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Extendicare Right Now?

Before you consider Extendicare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.

While Extendicare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.